New Zealand markets close in 4 hours 43 minutes
  • NZX 50

    12,198.14
    +7.08 (+0.06%)
     
  • NZD/USD

    0.6703
    -0.0009 (-0.14%)
     
  • NZD/EUR

    0.5915
    +0.0004 (+0.06%)
     
  • ALL ORDS

    7,441.50
    -48.60 (-0.65%)
     
  • ASX 200

    7,139.50
    -36.30 (-0.51%)
     
  • OIL

    84.10
    +0.79 (+0.95%)
     
  • GOLD

    1,843.00
    +1.30 (+0.07%)
     
  • NASDAQ

    14,509.58
    +71.18 (+0.49%)
     
  • FTSE

    7,297.15
    -196.98 (-2.63%)
     
  • Dow Jones

    34,364.50
    +99.13 (+0.29%)
     
  • DAX

    15,011.13
    -592.75 (-3.80%)
     
  • Hang Seng

    24,656.46
    -309.09 (-1.24%)
     
  • NIKKEI 225

    27,588.37
    +66.11 (+0.24%)
     
  • NZD/JPY

    76.3890
    +0.1100 (+0.14%)
     

Is West Pharmaceutical Services (WST) a Great Growth Stock?

·2-min read

Growth stocks can be some of the most exciting picks in the market, as these high-flyers can captivate investors’ attention, and produce big gains as well. However, they can also lead on the downside when the growth story is over, so it is important to find companies which are still seeing strong growth prospects in their businesses.

One such company that might be well-positioned for future earnings growth is West Pharmaceutical Services, Inc. WST. This firm, which is in the Medical - Dental Supplies industry, saw EPS growth of 46.9% last year, and is looking great for this year too.

In fact, the current growth estimate for this year calls for earnings-per-share growth of 77.1%. Furthermore, the long-term growth rate is currently an impressive 27.7%, suggesting pretty good prospects for the long haul.

West Pharmaceutical Services, Inc. Price and Consensus

West Pharmaceutical Services, Inc. Price and Consensus
West Pharmaceutical Services, Inc. Price and Consensus

West Pharmaceutical Services, Inc. price-consensus-chart | West Pharmaceutical Services, Inc. Quote

And if this wasn’t enough, the stock has actually seen estimates rise over the past month for the current fiscal year by about 2.5%. Thanks to this rise in earnings estimates, WST has a Zacks Rank #2 (Buy) which further underscores the potential for outperformance in this company. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

So if you are looking for a fast growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider WST. Not only does it have double-digit earnings growth prospects, but its impressive Zacks Rank suggests that analysts believe better days are ahead for WST as well.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

West Pharmaceutical Services, Inc. (WST) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting